Early Symptoms of Women’s Cancer
October 7, 2022
For all women, paying attention to the warning signs that your body is giving you is a critical part of early cancer detection.
HALO Diagnostics Info & Updates
Survivors’ Stories: Why Prostate Cancer Awareness Matters
September 30, 2022
Prostate cancer awareness matters year-round. Hear from our patients about the impact of HALO Diagnostics’ pioneering prostate treatments.
BRCA Genes and Women’s Cancer Risk
September 23, 2022
By detecting BRCA gene mutations earlier in their lives, women with breast cancer cases can be treated more successfully.
Why Multiomics is Healthcare’s Next Big Step
September 21, 2022
Healthcare experts like Dr. Chris Hancock are leveraging multiomics to take a proactive approach to detecting diseases sooner.
Are HPV and Breast Cancer Connected?
September 20, 2022
As researchers continue to study the connection between HPV and Breast Cancer, discover how you can lower your risk for both.
5 Myths about Breast Cancer and Vaccines
September 13, 2022
Since the onset of the pandemic, many myths have been formed around vaccines. Getting the right advice matters – especially when navigating breast cancer.
6 Steps to Reducing Your Prostate Cancer Risk
September 8, 2022
By following these 6 simple steps recommended by HALO Diagnostics, men can greatly reduce their risk of prostate cancer.
Breast Screenings: The Best Gift You Can Give
August 5, 2022
Breast screenings are crucial for all women 40 and over, and are also a great gift idea for all of the women in your life.
HALO Diagnostics, IncellDx Partner to Advance Novel Testing, Improve Standard of Care for Prostate and Bladder Cancers
June 29, 2022
The precision diagnostics leader and molecular diagnostics company are joining forces to develop new, innovative testing for urogenital cancers that will improve the standard of care.
HALO Diagnostics and Genomic Testing Cooperative Partner to Advance Early Cancer Detection and Precision Diagnostics
June 14, 2022
The companies have come together to provide personalized testing that expands the possibilities of early cancer detection and precision diagnostics.
